181 related articles for article (PubMed ID: 29719590)
1. 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.
Nagaprashantha LD; Singhal J; Li H; Warden C; Liu X; Horne D; Awasthi S; Salgia R; Singhal SS
Oncotarget; 2018 Apr; 9(26):18053-18068. PubMed ID: 29719590
[TBL] [Abstract][Full Text] [Related]
2. 2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76.
Singhal J; Chikara S; Horne D; Salgia R; Awasthi S; Singhal SS
Mol Carcinog; 2018 Dec; 57(12):1751-1762. PubMed ID: 30136444
[TBL] [Abstract][Full Text] [Related]
3. 2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells.
Nagaprashantha LD; Singhal J; Chikara S; Gugiu G; Horne D; Awasthi S; Salgia R; Singhal SS
J Proteomics; 2019 Feb; 192():233-245. PubMed ID: 30248461
[TBL] [Abstract][Full Text] [Related]
4. 2'-Hydroxyflavanone: A novel strategy for targeting breast cancer.
Singhal J; Nagaprashantha L; Chikara S; Awasthi S; Horne D; Singhal SS
Oncotarget; 2017 Sep; 8(43):75025-75037. PubMed ID: 29088842
[TBL] [Abstract][Full Text] [Related]
5. Topical 2'-Hydroxyflavanone for Cutaneous Melanoma.
Bose C; Singh SP; Igid H; Green WC; Singhal SS; Lee J; Palade PT; Rajan A; Ball S; Tonk V; Hindle A; Tarbox M; Awasthi S
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31615091
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of 2'-hydroxyflavanone towards lung cancer.
Awasthi S; Singhal SS; Singhal J; Nagaprashantha L; Li H; Yuan YC; Liu Z; Berz D; Igid H; Green WC; Tijani L; Tonk V; Rajan A; Awasthi Y; Singh SP
Oncotarget; 2018 Nov; 9(90):36202-36219. PubMed ID: 30546837
[TBL] [Abstract][Full Text] [Related]
7. Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice.
Singhal SS; Horne D; Singhal J; Vonderfecht S; Salgia R; Awasthi S
Mol Carcinog; 2019 Aug; 58(8):1438-1449. PubMed ID: 31006917
[TBL] [Abstract][Full Text] [Related]
8. RLIP inhibition suppresses breast-to-lung metastasis.
Singhal J; Chikara S; Horne D; Salgia R; Awasthi S; Singhal SS
Cancer Lett; 2019 Apr; 447():24-32. PubMed ID: 30684594
[TBL] [Abstract][Full Text] [Related]
9. Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-Hydroxyflavanone.
Singhal J; Singhal P; Horne D; Salgia R; Awasthi S; Singhal SS
Cancer Lett; 2018 Dec; 438():144-153. PubMed ID: 30223070
[TBL] [Abstract][Full Text] [Related]
10. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.
Jiang CF; Li DM; Shi ZM; Wang L; Liu MM; Ge X; Liu X; Qian YC; Wen YY; Zhen LL; Lin J; Liu LZ; Jiang BH
Oncotarget; 2016 Jun; 7(24):36940-36955. PubMed ID: 27175587
[TBL] [Abstract][Full Text] [Related]
11. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.
Chang CJ; Chiu JH; Tseng LM; Chang CH; Chien TM; Wu CW; Lui WY
Eur J Clin Invest; 2006 Aug; 36(8):588-96. PubMed ID: 16893382
[TBL] [Abstract][Full Text] [Related]
12. Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.
Nagaprashantha LD; Singhal J; Li H; Warden C; Liu X; Horne D; Awasthi S; Salgia R; Singhal SS
Oncotarget; 2022; 13():331. PubMed ID: 35261722
[TBL] [Abstract][Full Text] [Related]
13. 2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.
Nagaprashantha LD; Vatsyayan R; Singhal J; Lelsani P; Prokai L; Awasthi S; Singhal SS
Carcinogenesis; 2011 Apr; 32(4):568-75. PubMed ID: 21304051
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells.
Peng J; Jordan VC
Int J Oncol; 2010 Feb; 36(2):451-8. PubMed ID: 20043081
[TBL] [Abstract][Full Text] [Related]
15. Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines.
Rangel N; Villegas VE; Rondón-Lagos M
Breast Cancer (Dove Med Press); 2017; 9():537-550. PubMed ID: 29033607
[TBL] [Abstract][Full Text] [Related]
16. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.
Cvetkovic D; Dragan M; Leith SJ; Mir ZM; Leong HS; Pampillo M; Lewis JD; Babwah AV; Bhattacharya M
Endocrinology; 2013 Jun; 154(6):1999-2014. PubMed ID: 23525242
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibitory potencies and mechanisms of the type I ribosome inactivating protein marmorin on estrogen receptor (ER)-positive and ER-negative breast cancer cells.
Pan WL; Wong JH; Fang EF; Chan YS; Ye XJ; Ng TB
Biochim Biophys Acta; 2013 May; 1833(5):987-96. PubMed ID: 23274857
[TBL] [Abstract][Full Text] [Related]
18. RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
Leake K; Singhal J; Nagaprashantha LD; Awasthi S; Singhal SS
PLoS One; 2012; 7(4):e34582. PubMed ID: 22509328
[TBL] [Abstract][Full Text] [Related]
19. Rlip Depletion Suppresses Growth of Breast Cancer.
Bose C; Yadav S; Singhal SS; Singhal J; Hindle A; Lee J; Cheedella NKS; Rehman S; Rahman RL; Jones C; Darden M; Palade PT; Berz D; Singh SP; Awasthi S
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32498332
[TBL] [Abstract][Full Text] [Related]
20. Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.
Liu JC; Voisin V; Bader GD; Deng T; Pusztai L; Symmans WF; Esteva FJ; Egan SE; Zacksenhaus E
Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5832-7. PubMed ID: 22460789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
